Ikena Oncology, Inc. Contracts & Agreements

34 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Inmagene Biopharmaceuticals 2019 Stock Incentive Plan
Bonus & Incentive Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2025
Indemnification Agreement between ImageneBio, Inc. and Director/Officer
Indemnification Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2025
Employment Offer Letter between Inmagene LLC and Jonathan Wang (CEO) dated December 26, 2022
Employment Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2025
Employment Offer Letter for Chief Medical Officer between Inmagene LLC and Yufang Lu
Employment Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2025
Inmagene LLC Employment Offer Letter to Erin Butler for Vice President and Controller Position
Employment Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2025
Severance Rights Agreement between Inmagene Biopharmaceuticals and Jonathan Jian Wang
Severance Agreements
Ikena Oncology, Inc.
Pharmaceuticals
CA
2025
Severance Rights Agreement between Inmagene Biopharmaceuticals and Yufang Lu
Severance Agreements
Ikena Oncology, Inc.
Pharmaceuticals
CA
2025
Severance Rights Agreement between Inmagene Biopharmaceuticals and Erin Butler
Severance Agreements
Ikena Oncology, Inc.
Pharmaceuticals
CA
2025
Collaboration, Option and License Agreement between Inmagene Biopharmaceuticals and Hutchison MediPharma Limited
Collaboration Agreements
Ikena Oncology, Inc.
Pharmaceuticals
NY
2025
Consulting Agreement between Ikena Oncology, Inc. and M. Caroline Germa, M.D. (Effective February 4, 2025)
Consulting Agreements
Ikena Oncology, Inc.
Pharmaceuticals
NJ
2025
Separation Agreement between Ikena Oncology, Inc. and M. Caroline Germa, M.D.
Separation Agreements
Ikena Oncology, Inc.
Pharmaceuticals
MA
2025
Ikena Oncology, Inc. Retention Bonus Agreement with Jotin Marango (February 2025)
Bonus & Incentive Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2025
Ikena Oncology July 2024 Retention Cash Bonus Agreement with Mark Manfredi
Bonus & Incentive Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2024
Ikena Oncology July 2024 Retention Cash Bonus Agreement with Joti Marango
Bonus & Incentive Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2024
Consulting Agreement between Ikena Oncology, Inc. and SLSS Consulting, LLC (March 2024)
Consulting Agreements
Ikena Oncology, Inc.
Pharmaceuticals
MA
2024
Agreement and Plan of Merger among Ikena Oncology, Inc., Portsmouth Merger Subs, Pionyr Immunotherapeutics, Inc., and Fortis Advisors LLC
Merger Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2023
Ikena Oncology, Inc. 2021 Stock Option and Incentive Plan
Bonus & Incentive Agreements
Ikena Oncology, Inc.
Pharmaceuticals
MA
2021
Ikena Oncology, Inc. 2021 Employee Stock Purchase Plan
Bonus & Incentive Agreements
Ikena Oncology, Inc.
Pharmaceuticals
MA
2021
Ikena Oncology, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2021
Ikena Oncology, Inc. Director Indemnification Agreement
Indemnification Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2021
Employment Agreement between Ikena Oncology, Inc. and Executive
Employment Agreements
Ikena Oncology, Inc.
Pharmaceuticals
MA
2021
Agreement and Plan of Merger among Kyn Therapeutics Inc., Arrys Merger Sub, Inc., Arrys Therapeutics, Inc., and OrbiMed Private Investments VI, LP
Merger Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2021
Agreement and Plan of Merger among Ikena Oncology, Inc., AMI Merger Sub, Inc., Amplify Medicines, Inc., and Atlas Venture Fund XI, L.P.
Merger Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2021
Fourth Amended and Restated Investors' Rights Agreement among Ikena Oncology, Inc., Investors, and Key Holders
Investor Rights Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2021
Kyn Therapeutics Inc. 2016 Stock Incentive Plan
Bonus & Incentive Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2021
License Agreement between Arrys Therapeutics, Inc. and AskAt Inc. for EP4 Antagonist Technology
License Agreements
Ikena Oncology, Inc.
Pharmaceuticals
NY
2021
Patent License Agreement between The University of Texas at Austin and Kyn Therapeutics LLC
License Agreements
Ikena Oncology, Inc.
Pharmaceuticals
TX
2021
Lease Agreement Between OPG MP Parcel Owner (DE) LLC and Ikena Oncology, Inc. for 645 Summer Street, Boston, MA
Lease Agreements
Ikena Oncology, Inc.
Pharmaceuticals
MA
2021
Contingent Value Rights Agreement between Ikena Oncology, Inc. and Computershare Inc. (August 4, 2023)
Registration Rights Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2023
Underwriting Agreement between Ikena Oncology, Inc. and Underwriters for Sale of Common Stock
Underwriting Agreements
Ikena Oncology, Inc.
Pharmaceuticals
NY
2023
Description of Ikena Oncology, Inc. Capital Stock and Registration Rights
Registration Rights Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2022
Underwriting Agreement between Ikena Oncology, Inc. and Jefferies LLC, Cowen and Company, LLC, Credit Suisse Securities (USA) LLC, and William Blair & Company, L.L.C.
Underwriting Agreements
Ikena Oncology, Inc.
Pharmaceuticals
NY
2021
Ikena Oncology, Inc. Common Stock Certificate Issued to Alexander David Sample
Stock Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2021
Master Collaboration Agreement between Celgene Corporation and Kyn Therapeutics Inc. (January 11, 2019)
Collaboration Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2021